Form 4: DarioHealth CCO Nelson Acquires 30,000 Restricted Shares

DarioHealth Corp.'s President and CCO, Steven Charles Nelson, acquired 30,000 shares of common stock as a restricted award, increasing his beneficial ownership to 34,750 shares.

Summary

• Steven Charles Nelson, President and CCO of DarioHealth Corp. (DRIO), acquired 30,000 shares of common stock.
• The acquisition, dated September 11, 2025, was a restricted share award with a price of $0 per share.
• These restricted shares are scheduled to vest on the last day of the second-year anniversary after the grant date, which is September 11, 2027.
• Following this transaction, Nelson beneficially owns a total of 34,750 shares of DarioHealth Corp. common stock.
• The reported beneficial ownership reflects a 20-for-1 reverse stock split that was effected on August 28, 2025.

Sentiment

Score: 7

Explanation: The acquisition of restricted shares by a key executive is a positive signal of management's long-term commitment and alignment with shareholder value, indicating confidence in the company's future. While not an open market purchase, it strengthens insider ownership.

Positives

• Steven Charles Nelson, a key executive, increased his direct ownership in the company by 30,000 shares, signaling confidence in the company's future.
• The acquisition is a restricted share award, which aligns management's long-term interests with those of shareholders by tying compensation to future performance.

Future Outlook

NA

Industry Context

This insider transaction is a routine executive compensation event within the digital health industry, where equity awards are commonly used to incentivize leadership and align their interests with long-term company performance. It does not provide specific insights into broader industry trends or competitive positioning beyond the company's internal compensation strategy.

Comparison to Industry Standards

• Restricted stock awards are a standard component of executive compensation packages across various industries, including digital health, aligning executive incentives with shareholder value over a vesting period.
• The 20-for-1 reverse stock split is a corporate action often undertaken by companies to increase their share price, potentially to meet listing requirements or improve market perception, a practice observed in companies like DarioHealth Corp. within the broader market.

Related Party Transactions

• Steven Charles Nelson, President and CCO of DarioHealth Corp., received a restricted share award from the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The transaction increases the alignment of a key executive's financial interests with shareholder value through long-term equity ownership.
• Management: Steven Charles Nelson's compensation package is enhanced with long-term equity incentives, tying his financial success to the company's performance.

Next Steps

• The 30,000 restricted shares granted to Steven Charles Nelson will vest on September 11, 2027, subject to continued employment and any other specified conditions.

Key Dates

Recommendation

The acquisition of restricted shares by a key executive is a positive signal of management's long-term commitment and alignment with shareholder interests. However, as a grant rather than an open market purchase, it primarily reflects a compensation structure rather than a direct investment decision based on current market valuation. This transaction alone is not sufficient to change a broader investment thesis, thus a 'hold' recommendation is appropriate, maintaining current positions while monitoring further developments.

Keywords

DarioHealth, DRIO, Steven Nelson, Form 4, Insider Transaction, Restricted Stock Award, Executive Compensation, Beneficial Ownership, Reverse Stock Split